Lemska, A.; Ruminski, P.; Szymarek, J.; Studzinska, S.; Mazurkiewicz-Beldzinska, M.
Efficacy of Nusinersen Treatment in Type 1, 2, and 3 Spinal Muscular Atrophy: Real-World Data from a Single-Center Study. Neurol. Int. 2024, 16, 1266-1278.
https://doi.org/10.3390/neurolint16060096
AMA Style
Lemska A, Ruminski P, Szymarek J, Studzinska S, Mazurkiewicz-Beldzinska M.
Efficacy of Nusinersen Treatment in Type 1, 2, and 3 Spinal Muscular Atrophy: Real-World Data from a Single-Center Study. Neurology International. 2024; 16(6):1266-1278.
https://doi.org/10.3390/neurolint16060096
Chicago/Turabian Style
Lemska, Anna, Piotr Ruminski, Jakub Szymarek, Sylwia Studzinska, and Maria Mazurkiewicz-Beldzinska.
2024. "Efficacy of Nusinersen Treatment in Type 1, 2, and 3 Spinal Muscular Atrophy: Real-World Data from a Single-Center Study" Neurology International 16, no. 6: 1266-1278.
https://doi.org/10.3390/neurolint16060096
APA Style
Lemska, A., Ruminski, P., Szymarek, J., Studzinska, S., & Mazurkiewicz-Beldzinska, M.
(2024). Efficacy of Nusinersen Treatment in Type 1, 2, and 3 Spinal Muscular Atrophy: Real-World Data from a Single-Center Study. Neurology International, 16(6), 1266-1278.
https://doi.org/10.3390/neurolint16060096